Factor VII Human Chromogenic Activity Assay Kit (ab108830)
Key features and details
- Assay type: Enzyme activity (quantitative)
- Detection method: Colorimetric
- Platform: Microplate reader
- Assay time: 3 hr
- Sample type: Cell culture supernatant, Plasma, Serum
- Sensitivity: 4 mIU/ml
製品の概要
-
製品名
Factor VII Human Chromogenic Activity Assay Kit -
検出方法
Colorimetric -
再現性
Intra-Assay(同時再現性) サンプル N 平均値 SD CV% Overall 60 4.8% Inter-Assay(日差再現性) サンプル N 平均値 SD CV% Overall 60 10% -
サンプルの種類
Cell culture supernatant, Serum, Plasma -
アッセイタイプ
Enzyme activity (quantitative) -
検出感度
4 mIU/ml -
検出範囲
0.013 IU/ml - 0.2 IU/ml -
全工程の試験時間
3h 00m -
種交差性
交差種: Human -
製品の概要
Factor VII Human Chromogenic Activity Assay Kit (ab108830) has been developed to determine human FVII activity in plasma, serum and cell culture supernatants. The assay couples immunofunctional and indirect amidolytic assay. A polyclonal antibody specific for Human FVII has been pre-coated onto a microplate and active FVII is bound to the immobilized antibody. The assay measures the ability of lipoprotein TF/FVIIa to activate factor X (FX) to factor Xa. The amidolytic activity of the TF/FVIIa complex is quantitated by the amount of FXa produced using a highly specific FXa substrate releasing a yellow para-nitroaniline (pNA) chromophore. The change in absorbance of the pNA at 405 nm is directly proportional to the FVII enzymatic activity.
The entire kit may be stored at -20°C for long term storage before reconstitution - Avoid repeated freeze-thaw cycles.
-
特記事項
Factor VII (FVII) is a vitamin K-dependent plasma glycoprotein that is synthesized in the liver and circulates in blood as a single-chain inactive zymogen with a molecular mass of 50 kDa. Upon tissue damage and vascular injury, the cell surface receptor and cofactor tissue factor (TF) binds and allosterically activates FVII to its active form, FVIIa. The TF/FVIIa complex catalyzes the conversion of both factor IX to factor IXa and factor X to factor Xa to initiate coagulation via the extrinsic pathway. Very low levels of FVII are associated with severe coagulation disorders. Elevated plasma levels of FVII coagulant activity constitute an independent risk factor for fatal outcomes of coronary heart disease in middle-aged men.
-
試験プラットフォーム
Microplate reader
製品の特性
-
保存方法
Store at -20°C. Please refer to protocols. -
内容 100 tests 10X Diluent M Concentrate 1 x 20ml 20X Wash Buffer Concentrate 1 x 30ml Assay Diluent 1 x 20ml FXa Substrate 2 units Human FVII Microplate 1 x 96 units Human FVII Standard 1 unit Human FX 1 unit rhTF (lipoprotein) 1 unit Sealing Tapes 3 units -
研究分野
画像
データシートおよび資料
-
SDS download
-
Datasheet download
参考文献 (1)
ab108830 は 1 報の論文で使用されています。
- Hu Z et al. Targeting Tissue Factor for Immunotherapy of Triple-Negative Breast Cancer Using a Second-Generation ICON. Cancer Immunol Res 6:671-684 (2018). c3 ; Human . PubMed: 29622581